Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing Propofol Dosing for (Preterm) Newborn Infants That Need Endotracheal Intubation
NCT02040909Phase 1Terminated
- Sponsor
- Erasmus MC
- Start
- Jul 2014
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of propofol, sponsored by Erasmus MC. Primary endpoint: Appropriate dose of propofol in 8 different age groups at 24 hours. Started Jul 2014; status: terminated.
02
Drugs
propofol
Beyond the preview
Go deeper on NCT02040909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040909.